ClinConnect ClinConnect Logo
Search / Trial NCT03262675

NAtional TUnisian REgistry of Heart Failure

Launched by DACIMA CONSULTING · Aug 24, 2017

Trial Information

Current as of September 25, 2025

Completed

Keywords

Heart Failure Acute Heart Failure Chronic Heat Failure Cardiovascular Diseases Heart Diseases Registry Tunisia

ClinConnect Summary

The NATURE-HF is a national clinical non-interventional registry of heart failure, carried out in Tunisia at cardiology departments in hospitals and in liberal cardiology consultations. 100 cardiologists participate in the enrollment of the eligible patients as investigators. A Committee of Experts validates the protocol methodology and supervises the data-management. A Steering Committee helps investigators to monitor their patient inclusions, performs audit trails and prepares the statistical analysis plan for the study.

Collected data are managed by the DACIMA Clinical Suite®, the elect...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient with chronic heart failure
  • Patient with acute heart failure (new onset or not)
  • The diagnosis of heart failure is at the discretion of the investigator
  • Informed and signed consent
  • Exclusion Criteria:
  • Life expectancy \<12 months for extra cardiac disease
  • Isolated Right Heart Failure
  • Pregnant woman
  • Renal failure with creatinine clearance \< 15 ml / min
  • Hemodialysis patients
  • Cardiac surgery planned within 3 months
  • Congenital heart disease

About Dacima Consulting

Dacima Consulting is a leading clinical trial sponsor specializing in innovative solutions for the pharmaceutical and biotechnology industries. With a commitment to advancing healthcare, Dacima leverages cutting-edge technology and a team of experienced professionals to design, manage, and execute clinical trials efficiently and effectively. Their comprehensive services encompass protocol development, regulatory support, data management, and statistical analysis, ensuring high-quality results that facilitate the drug development process. Dacima Consulting is dedicated to enhancing patient outcomes through rigorous research, strategic collaboration, and a patient-centered approach.

Locations

Tunis, Tunisie, Tunisia

Patients applied

0 patients applied

Trial Officials

Faouzi Addad, Professor

Study Chair

Société Tunisienne de Cardiologie et de Chirurgie Cardiovasculaire

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials